EXECUTIVE CHANGES: Fresnillo chair steps down; Airtel Africa picks CEO
Thu, 29th Apr 2021 16:52
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:
Fresnillo PLC - gold and silver miner in Mexico - Alberto Bailleres steps down as chair and from board, effective immediately, but will remain as honorary president of Fresnillo. Alberto Bailleres, who is 89 years old, holds a 74.99% stake in Fresnillo, according to Morningstar. He will be replaced by Alejandro Bailleres, who is 60 and currently deputy chair. Fresnillo also proposes to add Hector Rangel as independent non-executive director and Eduardo Cepeda as non-executive director, both from the annual general meeting on June 24. Rangel is president of BCP Securities Mexico, a joint venture with US investment bank BCP Securities LLC. Cepeda was president & senior country officer at JP Morgan Chase & Co, based in Mexic
Thu, 29th Apr 2021 16:52
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:
Fresnillo PLC - gold and silver miner in Mexico - Alberto Bailleres steps down as chair and from board, effective immediately, but will remain as honorary president of Fresnillo. Alberto Bailleres, who is 89 years old, holds a 74.99% stake in Fresnillo, according to Morningstar. He will be replaced by Alejandro Bailleres, who is 60 and currently deputy chair. Fresnillo also proposes to add Hector Rangel as independent non-executive director and Eduardo Cepeda as non-executive director, both from the annual general meeting on June 24. Rangel is president of BCP Securities Mexico, a joint venture with US investment bank BCP Securities LLC. Cepeda was president & senior country officer at JP Morgan Chase & Co, based in Mexico City from 1993 to 2019. His an adviser to the BAL Group, so won t be c
Guildford, UK - 29 April 2021: Ergomed plc (LSE: ERGO) ( Ergomed or the Company ), a company focused on providing specialised services to the pharmaceutical industry, today announces that Dr. Llew Keltner, M.D., Ph.D., will join the Board as a Non-Executive Director with immediate effect. The Company also announces that Non-Executive Director, Ian Johnson, is stepping down from the Ergomed Board to focus on his other Board roles. Dr. Keltner brings over 30 years of experience across the life sciences sector, holding various senior positions with a particular focus on oncology and rare diseases. He has extensive experience of public and private financings, M&A, the formation of strategic partnerships and numerous transactions in the CRO, biotech and pharma sectors. While Chairman of Raptor Pharmaceuticals Inc., a US rare disease company, he led multiple financing rounds, product launches and the eventual sale of the Company to Horizon Phar